To better understand the role of HCV in lymphomagenesis in B-cell NHL, we performed a pathological study within the ANRS HC-13 LymphoC study [3], focusing on in situ the expression of the HCV NS3 protein. The gene discussed is KRAS; the disease is B-cell non-Hodgkin lymphoma.